Literature DB >> 3547210

Detection of Chlamydia trachomatis infection by direct immunofluorescence staining of genital secretion.

E Wiesmeier, D Bruckner, M Black.   

Abstract

A monoclonal antibody specific for Chlamydia trachomatis (Syva Microtrak) was used to stain directly 249, 127, and 67 specimens obtained from the cervix, and the female and the male urethra, respectively. The Microtrak system identified 100% or 23 culture-positive cases from the cervix (prevalence 9.2), 100% or seven culture-positive cases from the female urethra (prevalence 5.5%), and 93% or 14 culture-positive cases from the male urethra (prevalence 22.4%). Because the Microtrak system is readily available, relatively inexpensive, and easy to read with a fluorescent microscope, it should become a valuable tool to assess objectively both men and women suspect for this common sexually transmitted disease.

Entities:  

Mesh:

Year:  1987        PMID: 3547210

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  5 in total

1.  Screening for chlamydial cervicitis in a sexually active university population.

Authors:  C K Malotte; E Wiesmeier; K J Gelineau
Journal:  Am J Public Health       Date:  1990-04       Impact factor: 9.308

2.  The prevalence of Chlamydia infection in outpatient clinics in Beijing, China.

Authors:  A P Ni; C X Gu; S T Li; H Y Yang; B Wang; M Y Gai; M J Chen; Q S Ge
Journal:  Genitourin Med       Date:  1990-04

3.  Endocervical Chlamydia trachomatis infection in Canadian adolescents.

Authors:  E G Hughes; J Mowatt; J E Spence
Journal:  CMAJ       Date:  1989-02-01       Impact factor: 8.262

4.  Periodic health examination, 1996 update: 2. Screening for chlamydial infections. Canadian Task Force on the Periodic Health Examination.

Authors:  H D Davies; E E Wang
Journal:  CMAJ       Date:  1996-06-01       Impact factor: 8.262

Review 5.  Laboratory diagnosis of human chlamydial infections.

Authors:  R C Barnes
Journal:  Clin Microbiol Rev       Date:  1989-04       Impact factor: 26.132

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.